Ardelyx (ARDX) Common Equity (2013 - 2026)
Ardelyx (ARDX) reported Common Equity of $149.01 million for Q2 2026, up 6.8% from $139.53 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Ardelyx (ARDX) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Ardelyx posted Common Equity of $166.95 million, down 3.7% from FY2024.
- Common Equity has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- By year, Common Equity came in at $173.29 million in FY2024 (+3.9%), $166.82 million in FY2023 (+69.7%), $98.33 million in FY2022 (+19.0%) and $82.62 million in FY2021 (-34.5%).
- Five-year quarterly Common Equity spans a low of $53.04 million in Q2 2022 and a high of $191.16 million in Q3 2023.
- Year over year, Common Equity gained in three of the last eight quarters, with an average decline of 2.4%.
- The high point for year-over-year Common Equity in five years was Q3 2023 (growth of 185.9%); the low point was Q2 2022 (a decline of 54.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $148.62 million (Q1 2026), $166.95 million (Q4 2025) and $154.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Ardelyx | 849.59 Mn | -177.71 Mn | 115.12 Mn | 149.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.01 Mn |
| Mar 31, 2026 | 148.62 Mn |
| Dec 31, 2025 | 166.95 Mn |
| Sep 30, 2025 | 154.28 Mn |
| Jun 30, 2025 | 139.53 Mn |
| Mar 31, 2025 | 145.68 Mn |
| Dec 31, 2024 | 173.29 Mn |
| Sep 30, 2024 | 158.30 Mn |
| Jun 30, 2024 | 146.99 Mn |
| Mar 31, 2024 | 150.89 Mn |
| Dec 31, 2023 | 166.82 Mn |
| Sep 30, 2023 | 191.16 Mn |
| Jun 30, 2023 | 123.16 Mn |
| Mar 31, 2023 | 125.42 Mn |
| Dec 31, 2022 | 98.33 Mn |
| Sep 30, 2022 | 66.86 Mn |
| Jun 30, 2022 | 53.04 Mn |
| Mar 31, 2022 | 64.19 Mn |
| Dec 31, 2021 | 82.62 Mn |
| Sep 30, 2021 | 81.43 Mn |
API Access
Ardelyx Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();